3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other solid neoplasm
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Sarcoma
17
Glioblastoma
10
Brain Neoplasms
10
Gliosarcoma
9
Rhabdomyosarcoma
7
Osteosarcoma
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Sarcoma, Ewing
5
Recurrence
5
Leukemia, Myeloid, Acute
5
Dendritic Cell Sarcoma, Interdigitating
5
Burkitt Lymphoma
5
Astrocytoma
5
Oligodendroglioma
4
Myeloproliferative Disorders
4
Myelodysplastic Syndromes
4
Multiple Myeloma
4
Lymphoma, Non-Hodgkin
4
Lymphoma, Mantle-Cell
4
Lymphoma, Follicular
4
Lymphoma, B-Cell, Marginal Zone
4
Lymphoma
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Leukemia
4
Hodgkin Disease
4
Glioma
4
Rhabdoid Tumor
3
Primary Myelofibrosis
3
Neurofibrosarcoma
3
Neuroblastoma
3
Interventions
Cyclophosphamide
4
Topotecan
3
Ifosfamide
3
Doxorubicin
3
seclidemstat
2
pazopanib
2
Biopsy
2
tebentafusp
1
selinexor
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
fludarabine phosphate
1
fludarabine
1
dostarlimab
1
devimistat
1
cobimetinib
1
cabozantinib
1
atezolizumab
1
Zoledronic Acid
1
X-Rays
1
Vemurafenib
1
Sunitinib
1
Specimen Handling
1
Sirolimus
1
Simvastatin
1
Radiotherapy, Image-Guided
1
Radiotherapy
1
Radiation Dose Hypofractionation
1
Radiation
1
Proton Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sarcoma, Clear Cell
×
Sirolimus
×
Sarcoma
×
Clear all
NCT01331135
2020-05-29
Aflac ST0901
Emory University
Phase 1
Completed
18 enrolled